Skip to content

Magnetic resonance imaging (MRI) fluoroscopy for imaging childhood vesicoureteric reflux

Magnetic resonance imaging (MRI) replacement of x-ray fluoroscopy in paediatric imaging: an investigation of vesicoureteric reflux

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ISRCTN
Registry ID
ISRCTN98320102
Enrollment
50
Registered
2010-07-07
Start date
2008-09-01
Completion date
Unknown
Last updated
2017-08-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Topic: Generic Health Relevance and Cross Cutting Themes

Interventions

All patients volunteering for this study will undergo conventional XR fluoroscopy as per standard care, followed by an additional MRI examination. Data collection involves completion of demographic pr

Sponsors

Cambridge University Hospitals NHS Foundation Trust (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. All children (usually boys) between the ages of 0 and 3 years referred for direct micturating cysto-urethrography (MCUG) 2. All children with hydronephrosis diagnosed antenatally on foetal ultrasound 3. Age range: 0 days - 3 years, male and female

Exclusion criteria

Exclusion criteria: 1. Usual MR exclusion criteria will apply, but are highly unlikely in this age group. The include pregnancy, claustrophobia, cardiac pacemakers, metallic implants, cardiac defibrillator implants, aneurysm clips or metallic heart valves, and cochlear or inner ear implants. These exclusion criteria clearly apply to all people within the vicinity of the MRI scanner, and therefore apply equally to the parents/guardians in this study. 2. Previous reaction to the relevant x-ray or MRI contrast medium (including gadolinium) 3. Congenital abnormalities that make X-ray fluoroscopy of MR fluoroscopy impractical

Design outcomes

Primary

MeasureTime frame
The ability of the MR fluoroscopy examination to accurately detect: 1. Significant grade VUR likely to alter clinical management 2. The presence of posterior urethral ballooning Assessed at the time of the intervention

Secondary

MeasureTime frame
Assessed at the time of the intervention: 1. Image quality 2. Artifacts

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026